MTOR and neoplasm: Alternatively, AKR1B1 inhibition could prevent activation of the mTOR pathway through 5' adenosine monophosphate‐activated protein kinase (AMPK) activation as it prevents phosphorylation of mTOR, Raptor, eIF4E, S6K and 4E‐BP1, thereby inhibiting tumour growth.